Calcitonin gene-related peptide 1 (16-25)

Calcitonin gene-related peptide 1 (16-25) is a synthetic peptide fragment derived from the C-terminal region of the human calcitonin gene-related peptide (CGRP) sequence. As a biologically relevant peptide segment, it retains specific structural and functional motifs associated with the parent CGRP molecule, a neuropeptide known for its roles in vasodilation, nociception, and neurogenic inflammation. The 16-25 fragment is of particular interest for researchers investigating the structure-activity relationships of CGRP, as well as those seeking to delineate the minimal functional domains responsible for receptor binding and downstream signaling. Its defined sequence enables targeted studies into peptide-receptor interactions, making it a valuable tool in neurobiology, pharmacology, and peptide engineering.

Receptor binding studies: As a well-defined segment of the CGRP molecule, the 16-25 fragment is frequently utilized in receptor binding assays to map the functional domains necessary for interaction with the CGRP receptor complex. By comparing the binding affinities and activities of this fragment with those of the full-length peptide and other truncated analogs, researchers can elucidate the critical amino acid residues involved in receptor recognition and activation. This approach aids in the rational design of peptide-based agonists or antagonists and advances understanding of peptide-receptor specificity.

Structure-activity relationship analysis: The CGRP 16-25 fragment serves as a model system for dissecting the structural features that govern biological activity within the CGRP family of peptides. Detailed analysis of this segment enables scientists to assess the contribution of particular residues to secondary structure formation, receptor engagement, and biological function. Such studies are fundamental in peptide chemistry and help inform the development of modified peptides with tailored bioactivity or improved stability for research purposes.

Peptide synthesis and modification: The defined sequence of the 16-25 fragment makes it a valuable substrate for peptide synthesis optimization and site-specific modification studies. Researchers often employ this fragment to test novel synthetic methodologies, introduce non-natural amino acids, or incorporate functional tags for downstream analytical applications. These efforts contribute to advances in solid-phase peptide synthesis and facilitate the creation of custom peptide probes for mechanistic studies.

Neurobiological pathway investigation: As CGRP is implicated in a range of neural signaling processes, the 16-25 peptide fragment is used to probe the molecular mechanisms underlying neurogenic inflammation and pain transmission. By applying this fragment in in vitro or ex vivo models, scientists can dissect the contribution of specific peptide domains to neuronal activation, signal transduction, and the modulation of inflammatory mediators. Such studies provide insights into the fundamental biology of neuropeptide signaling.

Analytical standard for detection and quantification: In peptide analytics, the CGRP 16-25 fragment is employed as a reference standard for method development and validation in mass spectrometry or chromatographic assays. Its defined composition and physicochemical properties enable precise calibration, facilitating the accurate identification and quantification of CGRP-related peptides in complex biological samples. This application is essential for quality control, biomarker discovery, and advanced proteomic analyses.

1. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

2. TMEM16F and dynamins control expansive plasma membrane reservoirs

3. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum